Advertisement

Reactions Weekly

, Volume 1734, Issue 1, pp 30–30 | Cite as

Alemtuzumab

Alopecia areata: 2 case reports
Case report

Reference

  1. Alcala C, et al. Recurrent and universal alopecia areata following alemtuzumab treatment in multiple sclerosis: A secondary autoimmune disease. Multiple Sclerosis and Related Disorders 27: 406-408, Jan 2019. Available from: URL: http://doi.org/10.1016/j.msard.2018.12.005 - SpainCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations